Pharmaceuticals | |
Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors | |
Hiroshi Fujiwara1  | |
[1] Department of Hematology, Clinical Immunology and Infectious Disease, Graduate School of Medicine, Ehime University, Toon, Ehime 791-0295, Japan; E-Mail | |
关键词: adoptive immunotherapy; gene-modified T cell; T-cell receptor; chimeric antigen receptor; hematological malignancy; | |
DOI : 10.3390/ph7121049 | |
来源: mdpi | |
【 摘 要 】
Accumulating clinical evidence suggests that adoptive T-cell immunotherapy could be a promising option for control of cancer; evident examples include the graft-
【 授权许可】
CC BY
© 2014 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190018546ZK.pdf | 741KB | download |